ENTITY

SMARTSCORE: 3.6/5

SanBio Co Ltd (4592 JP)

34

Analysis

Health Care • Japan

Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.

more

Refresh

Exchange Announcement • 18 Mar 2025 06:30

Presentation For Financial Results For The Fiscal Year Ending January 31, 2025

Exchange Announcement • 17 Mar 2025 06:30

Consolidated Financial Results For The Fiscal Year Ended January 31, 2025 [Japanese Gaap]

Exchange Announcement • 17 Mar 2025 06:30

Notice Concerning Recording Of Non-Operating Income, Non-Operating Expenses, Extraordinary Gains, And Deferred Income Taxes

Exchange Announcement • 17 Mar 2025 06:30

Notice Concerning Differences Between Consolidated Earnings Forecast And Actual Results For The Fiscal Year Ending January 31, 2025

Exchange Announcement • 17 Mar 2025 06:30

Announcement On Reduction In Amounts Of Stated Capital And Capital Reserves And Appropriation Of Other Capital Surplus

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.51.2

x